Among them, we detected strong and very strong HER2 expression by the breast cancer cell lines MCF7 and MDA-MB-453, respectively, compared to low to intermediate HER2 surface expression by MDA-MB-231 cells. The gene discussed is ERBB2; the disease is breast carcinoma.